HUTCHMED (China) (HCM) Operating Expenses (2018 - 2021)
HUTCHMED (China)'s (HCM) quarterly Operating Expenses came in at -$156.3 million in Q2 2021, down 54.99% year-on-year from -$347.4 million in Q2 2020, and down 8.0% on a QoQ basis from -$144.8 million in Q1 2021.
HUTCHMED (China) (HCM) Operating Expenses (2018 - 2021) Analysis & Trends
HUTCHMED (China) (HCM) has 4 years of Operating Expenses data on file, last reported at -$156.3 million in Q2 2021.
- On a quarterly basis, Operating Expenses fell 54.99% year-over-year to -$156.3 million in Q2 2021; TTM through Dec 2022 was -$156.3 million, a 48.08% increase from a year earlier, with the FY2025 full-year figure at -$75.6 million, up 12.51% from the prior year.
- Operating Expenses for Q2 2021 stood at -$156.3 million, down from -$144.8 million in the prior quarter.
- Over the last five years, Operating Expenses for HCM reached as high as $233.2 million in Q2 2018 and fell as low as -$262.4 million in Q2 2019.
- Historically, Operating Expenses has averaged -$44.2 million across 4 years, with a median of -$84.7 million in 2019.
- On a YoY basis, Operating Expenses climbed as much as 214.04% in 2019 and fell as far as 218.76% in 2019.
- Year by year, Operating Expenses stood at $77.3 million in 2018, then plunged by 218.76% to -$91.8 million in 2019, then dropped by 9.9% to -$100.9 million in 2020, then sank by 54.99% to -$156.3 million in 2021.
- Per Business Quant data, the three most recent Operating Expenses figures were -$156.3 million in Q2 2021, -$144.8 million in Q1 2021, and -$100.9 million in Q2 2020.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 1.00 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 788.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 12.58 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 455.70 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 1.24 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 621.10 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 494.00 Mn |
| 10 | HUTCHMED (China) | 241.90 Mn | 243.61 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2021 | -156.34 Mn |
| Mar 31, 2021 | -144.76 Mn |
| Jun 30, 2020 | -100.87 Mn |
| Mar 31, 2020 | -84.06 Mn |
| Dec 31, 2019 | -91.78 Mn |
| Sep 30, 2019 | -85.29 Mn |
| Jun 30, 2019 | -262.43 Mn |
| Mar 31, 2019 | 88.22 Mn |
| Dec 31, 2018 | 77.28 Mn |
| Sep 30, 2018 | 73.60 Mn |
| Jun 30, 2018 | 233.23 Mn |
| Mar 31, 2018 | -77.36 Mn |